Christopher J. Nardo - 04 Jan 2024 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DRMA	Stock Option (right to buy	Award	$0	+50,000		$0.000000	50,000	04 Jan 2024	Common Stock	50,000	$0.6099	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.